CA Patent

CA3077088A1 — Process for preparing spiro derivatives

Assigned to Biogen Inc · Expires 2019-04-18 · 7y expired

What this patent protects

The invention relates to a novel process for preparing spiro derivatives, in particular 7-methyl- 2-[4-methyl-6-[4-(trifluoromethyl)-phenyl]pyrimidin-2-yl]-1,7-diazaspiro[4.4]nonan-6-one, and to novel intermediates for use in said process along with processes for preparing said i…

USPTO Abstract

The invention relates to a novel process for preparing spiro derivatives, in particular 7-methyl- 2-[4-methyl-6-[4-(trifluoromethyl)-phenyl]pyrimidin-2-yl]-1,7-diazaspiro[4.4]nonan-6-one, and to novel intermediates for use in said process along with processes for preparing said intermediates.

Drugs covered by this patent

Patent Metadata

Patent number
CA3077088A1
Jurisdiction
CA
Classification
—
Expires
2019-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Biogen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.